AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,777,651 | +80.9% | 289,906 | +0.5% | 0.42% | +67.9% |
| Q1 2023 | $2,641,057 | +299.6% | 288,325 | +91.5% | 0.25% | +287.7% |
| Q3 2018 | $661,000 | -30.9% | 150,600 | -3.4% | 0.06% | -33.7% |
| Q2 2018 | $956,000 | -37.6% | 155,971 | -25.7% | 0.10% | -41.7% |
| Q1 2018 | $1,531,000 | +6.5% | 210,012 | +61.2% | 0.17% | -8.7% |
| Q2 2017 | $1,437,000 | -19.3% | 130,311 | -29.1% | 0.18% | -20.3% |
| Q1 2017 | $1,780,000 | – | 183,866 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |